Sign in
4

Changes in Ownership

Enveric Biosciences, Inc. Filed Acc 0001493152-21-023862

Options or other derivatives

  • Director acquired 53,160 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Thompson Bradley George Director 2021-09-16 Grant or award · Stock Options +53,160 53,160 D
Loading xslF345X03/ownership.xml…